Martin Cloutier
Education
M.Sc. and B.S., economics, University of Quebec at Montreal
Summary of Experience
Mr. Cloutier is a health economist specializing in health economics and outcomes research (HEOR). He has conducted research on a diverse range of disease and therapeutic areas, including dermatology, hematology, immunology, nephrology, oncology, psychiatry, and hereditary and rare diseases. His areas of expertise in HEOR include large database and medical claims analyses, direct medical and indirect productivity costs of disease, safety profiles, real-world treatment patterns, clinical effectiveness, medication compliance, and medical chart reviews.
Mr. Cloutier’s research has been published in numerous peer-reviewed journals, including the Journal of the American Academy of Dermatology and the Journal of Clinical Psychiatry. This research has also been presented at dozens of international conferences, including the American Society of Clinical Oncology (ASCO) and the Annual Meeting of the American Academy of Dermatology. He has also served as a peer reviewer for several journals, including JAMA.
In addition to his HEOR experience, Mr. Cloutier has also worked extensively on high-profile litigation cases in which he coauthored reports or supported other experts. His recent work in the litigation area includes estimations of health care damages and economic analyses of labor and employment issues.
-
Economic Burden of Illness among Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disorders (CTD)
Pulmonary Circulation, 2023
2023Tsang Y, Panjabi S, Funtanilla V, Germack HD, Gauthier-Loiselle M, Manceur AM, Liu S, Cloutier M, Lefebvre P
-
Treatment Patterns among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis
Advances in Therapy, 2023
2023Schein J, Childress A, Gagnon-Sanschagrin P, Maitland J, Bedard J, Cloutier M, Guérin A
-
Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD
Current Medical Research and Opinion, 2022
2022Schein J, Cloutier M, Gauthier-Loiselle M, Bungay R, Guerin A, Childress A
-
Identifying Individuals with Undiagnosed Post-Traumatic Stress Disorder in a Large United States Civilian Population – A Machine Learning Approach
BMC Psychiatry, 2022
2022Gagnon-Sanschagrin P, Schein J, Urganis A, Serra E, Liang Y, Musingarimi P, Cloutier M, Guérin A, Davis L
-
Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States - a retrospective claims analysis
BMC Psychiatry, 2022
2022Schein J, Childress A, Adams J, Gagnon-Sanschagrin P, Maitland J, Qu W, Cloutier M, Guérin A
-
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective
Journal of Medical Economics, 2022
2022Schein J, Adler LA, Childress A, Cloutier M, Gagnon-Sanschagrin P, Davidson M, Kinkead F, Guerin A, Lefebvre P
-
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study
BMC Psychiatry, 2022
2022Schein J, Childress A, Cloutier M, Desai U, Chin A, Simes M, Guerin A, Adams J
-
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective
The Journal of Clinical Psychiatry, 2022
2022Davis LL, Schein J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Urganus A, Guerin A, Lefebvre P, Houle CR
-
Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective
Journal of Managed Care & Specialty Pharmacy, 2022
2022Schein J, Adler LA, Childress A, Gagnon-Sanschagrin P, Davidson M, Kinkead F, Cloutier M, Guérin A, Lefebvre P
-
Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey
Kidney Medicine, 2022
2022Michalopoulos SN, Gauthier-Loiselle M, Aigbogun MS, Serra E, Bungay R, Clynes D, Cloutier M, Kahle E, Guérin A, Farag YMK, Wish JB
-
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study
Advances in Therapy, 2022
2022Schein J, Cloutier M, Gauthier-Loiselle M, Bungay R, Guerin A, Childress A
-
Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States
Current Medical Research and Opinion, 2021
2021Willey C, Gauthier-Loiselle M, Cloutier M, Shi S, Maitland J, Stellhorn R, Sanon Aigbogun M
-
Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study
Current Medical Research and Opinion, 2021
2021Schein J, Childress A, Adams J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Bungay R, Guérin A, Lefebvre P
-
Prevalence of post-traumatic stress disorder in the United States: a systematic literature review
Current Medical Research and Opinion, 2021
2021Schein J, Houle C, Urganus A, Cloutier M, Patterson-Lomba C, Wang Y, King S, Levinson W, Guérin A, Lefebvre P, Davis LL
-
Mental Health and Health-Related Quality of Life Among Nephrology Nurses: A Survey-Based Cross-Sectional Study
Nephrology Nursing Journal, 2021
2021Montoya V, Donnini K, Gauthier-Loiselle M, Sanon M, Cloutier M, Maitland J, Guérin A, Dutka P, Pryor L, Thomas-Hawkins C, Voegel A, Hoffmann M, Savin S, Kurzman A, Kear T
-
Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective
Journal of Managed Care & Specialty Pharmacy, 2021
2021Gauthier-Loiselle M, Michalopoulos SN, Cloutier M, Serra E, Bungay R, Szabo E, Guérin A
-
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage
Journal of Medical Economics, 2021
2021Gagnon-Sanschagrin P, Liang Y, Sanon M, Oberdhan D, Guérin A, Cloutier M
-
Impact of agitation in long-term care residents with dementia in the United States
International Journal of Geriatric Psychiatry, 2021
2021Fillit H, Aigbogun MS, Gagnon-Sanschagrin P, Cloutier M, Davidson M, Serra E, Guérin A, Baker RA, Houle CR, Grossberg G
-
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Advances in Therapy, 2021
2021Gauthier-Loiselle M, Cloutier M, Toro W, Patel A, Shi S, Davidson M, Bischof M, LaMarca N, Dabbous O
-
The societal economic burden of autosomal dominant polycystic kidney disease in the United States
BMC Health Services Research
2020Cloutier M, Manceur AM, Guerin A, Aigbogun MS, Oberdhan D, Gauthier-Loiselle M
-
Economic burden of spinal muscular atrophy in the United States: a contemporary assessment
Journal of Medical Economics, 2020
2020Droege M, Sproule D, Arjunji R, Gauthier-Loiselle M, Cloutier M, Dabbous O
-
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
Journal of Alzheimer's Disease, 2020
2020Aigbogun MS, Cloutier M, Gauthier-Loiselle M, Guerin A, Ladouceur M, Baker RA, Grundman M, Duffy RA, Hartry A, Gwin K, Fillit H
-
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1
Advances in Therapy, 2019
2019Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM
-
Institutionalization risk and costs associated with agitation in Alzheimer's disease
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019
2019Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guerin A, Hartry A, Baker RA, Duffy R, Gwin K, Aigbogun MS
-
Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis
J Drugs Dermatol. Feb 1 2018;17(2):180-186
2018Kimball AB, Sundaram M, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A, Ganguli A
-
Assessment of costs associated with adverse events in patients with cancer
PloS One. 2018;13(4):e0196007
2018Wong W, Yim YM, Kim A, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A
-
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis
J Drugs Dermatol. Feb 1 2018;17(2):187-194
2018Paller AS, Singh R, Cloutier M, Gauthier-Loiselle M, Emond B, Guérin A, Ganguli A
-
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study
Journal of the American Academy of Dermatology. 2018 Jul;79(1):60-68
2018Wu JJ, Sundaram M, Cloutier M, Gauthier-Loiselle M, Guérin A, Singh R, Ganguli A
-
A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States
Journal of Medical Economics. 2018 Dec;21(12):1183-1190
2018Cloutier M, Greene M, Touya M, Gagnon-Sanschagrin P, Guérin A
-
Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis
Journal of Drugs in Dermatology, 2018
2018Wu J, Armstrong A, Singh R, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Arikan D, Fleischer A, Guérin A, Ganguli A
-
The economic burden of bipolar I disorder in the United States in 2015
Journal of Affective Disorders. Jan 15 2018;226:45-51
2017Cloutier M, Greene M, Guerin A, Touya M, Wu E
-
Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-alpha inhibitors versus methotrexate
Journal of the American Academy of Dermatology. Jan 2017;76(1):81-90
2017Wu JJ, Guérin A, Sundaram M, Dea K, Cloutier M, Mulani P
-
The Economic Burden of Schizophrenia in the United States in 2013
Journal of Clinical Psychiatry, June 2016;77(6):764-71
2016 -
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications
J Med Econ. 2013 Nov;16(11):1275-89
2015Setyawan J, Guerin A, Hodgkins P, Gauthier G, Cloutier M, Wu E, Erder MH
-
Real-world treatment patterns of gout patients treated with colchicine or other common treatments for gout in acute care settings: a retrospective chart review study
Current Medical Research and Opinion. 2015
2015Shiozawa A, Cloutier M, Heroux J, Guerin A, Wu EQ, Jackson R
-
Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants
Current Medical Research & Opinion, August 2014, Vol. 30, No. 8
2014Laliberte F, Coleman CI, Bookhart B, Lefebvre P, Cloutier M, Damaraju CV, Schein JR, Kaatz S
-
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
Current Medical Research & Opinion, July 2014, Vol. 30, No. 7
2014Laliberte F, Cloutier M, Nelson WW, Coleman CI, Pilon D, Olson WH, Damaraju CV, Schein JR, Lefebvre P
-
Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy
Int J Cardiol. 2013 Jul 31;167(2):564-9
2013Guerin A, Lin J, Jhaveri M, Wu EQ, Yu AP, Cloutier M, Gauthier G, Alpert JS
-
Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and
J Med Econ. 2013 Oct;16(10):1203-15
2013Setyawan J, Hodgkins P, Guerin A, Gauthier G, Cloutier M, Wu E, Erder MH
-
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis
J Med Econ. 2013 Jul;16(7):962-75
2013Setyawan J, Hodgkins P, Guerin A, Gauthier G, Cloutier M, Wu EQ, Erder MH
-
Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers
Journal of Medical Economics, 1-30, November 27, 2012
2012Ray S, Bonthapally V, Holen K, Gauthier G, Wu EQ, Cloutier M, Guérin A
-
October 23, 2023
-
March 22, 2023
-
October 17, 2022
-
April 13, 2021
